1. Pregnant.
  2. Sickle cell anemia and multiple myeloma.
  3. Previous reaction
  4. Asthmatic patient, DM & Atopic dermatitis
  5. Renal impairment >> contrast might cause acute renal failure.
  6. Some drug which may cause adverse reactions in association with iodinated contrast: −e.g. Metformin Z

Type of reaction

Mild: Signs and symptoms appear self-limited without evidence of progression

  • Nausea, vomiting -Altered taste -Sweats
  • Cough -Itching -Rash, hives
  • Warmth (heat) -Pallor -Nasal stuffiness
  • Headache -Flushing -Swelling: eyes, face
  • Dizziness -Chills –Anxiety.

Moderate: Reactions which require treatment but are not immediately life-threatening

  • Tachycardia/bradycardia - Hypotension/Hypertension
  • Moderate bronchospasm, wheezing -Dyspnea -Laryngeal edema
  • Pronounced cutaneous edema
  • treatment with antihistamine, hydrocortisone.

Severe: Life-threatening with more severe signs or symptoms including:

  • Laryngeal edema
  • Profound hypotension
  • Unresponsiveness
  • Convulsions (Severe or progressive)
  • Cardiopulmonary arrest
  • Clinically manifest arrhythmias
  • Treatment with; Epinephrine, Atropine

Anaphylaxis: Occurs soon after injection


Contrast allergy premedication

Indication: individuals at high risk for severe repeat DHRs (e.g., anaphylaxis) to radiocontrast media.

Contraindication: history of severe reactions (e.g., SJS (Stevens-Johnson syndrome) after radiocontrast media.

- Prednison


Contrast-induced nephropathy

DefinitionAKI after IV administration of iodinated contrast medium

Risk factors

  • Chronic kidney disease (CKD): diabetes mellitus, multiple myeloma

  • Congestive heart failure, arterial hypotension

  • Nephrotoxic drugs: esp. NSAIDs

  • Anemia

  • Dehydration

    Course: Creatinine is highest 3–5 days after injury and usually falls back to the baseline level within 1 week.

    Prevention of contrast-induced nephropathy
  • Always evaluate kidney function before administering a contrast agent.

  • Use a low dose and low concentration of contrast medium.

  • The patient should discontinue nephrotoxic substances before administration.

  • Ensure hydration: isotonic NaCl before and after administration of contrast medium